Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices
Authors:
Open Access
- 18 March 2016
- journal article
- research article
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 04 (03) , E371-E377
Abstract
Background and study aims: Patients with a continuous-flow left ventricular assist device (LVAD) have a 65 % incidence of bleeding events within the first year. The majority of gastrointestinal bleeding (GIB) is from gastrointestinal angiodyplasia (GIAD). The primary aim of the study was to determine whether GIAD was associated with a higher rate of significant bleeding, an increased number of bleeding events per year, and a higher rate of transfusion compared to non-GIAD sources. Patients and methods: This retrospective cohort study included 118 individuals who received a LVAD at a tertiary medical center from 2006 through 2014. Patients were subdivided into GIB and non-GIB for comparison of patient demographics, comorbid conditions, and laboratory data. GIB was further divided into sources of GIB, GIAD, obscure, or non-GIAD to establish severity of bleeding, rate of re-bleeding, and transfusion rate. Results: GIAD is associated with an increased number of bleeding events compared to non-GIAD sources of GIB (2.07 vs 1.23, P = 0.01) and a higher number of bleeding events per year (0.806 vs. 0.455 P = 0.001). GIAD compared to non-GIAD sources of GIB was associated with an increased incidence of major bleeding (100 % vs 60 %, P = 0.006) and increased rates of transfusion (8.8 vs 2.95 units, P = 0.0004). Cox Regression analysis between non-GIB and GIAD demonstrated increased risk with age (P = 0.001), history of chronic kidney disease (P = 0.005), and length of stay after LVAD implantation of more than 45 days (P = 0.04). History of hypertension (P = 0.045), diabetes mellitus (P = 0.016), and male gender was associated with decreased risk (P = 0.04). Conclusion: Patients with a continuous-flow LVAD who develop a GIB secondary to GIAD have a higher rate of major bleeding, multiple bleeding events, and require more transfusions to achieve stabilization compared to patients who do not have GIAD.Keywords
This publication has 25 references indexed in Scilit:
- Factors determining post-operative readmissions after left ventricular assist device implantationThe Journal of Heart and Lung Transplantation, 2014
- GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysisGastrointestinal Endoscopy, 2014
- Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate IICirculation: Heart Failure, 2013
- Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device RecipientsThe Annals of Thoracic Surgery, 2010
- Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control studyBMC Gastroenterology, 2010
- Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implantsThe Journal of Heart and Lung Transplantation, 2010
- Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devicesThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Gastric Mucosal Defense and Cytoprotection: Bench to BedsideGastroenterology, 2008
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- Increased Expression of Angiogenic Factors in Human Colonic AngiodysplasiaAmerican Journal of Gastroenterology, 1999